menu
    • menu

    Company profile for Vivet Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vivet Therapeutics is a gene therapy biotech company with headquarters in Paris, France, dedicated to the research, development and future commercialization of gene therapy treatments for inherited liver disorders with high medical need. The company's development strategy is to target the liver using a liver tropic adeno associated virus to introduce therapeutic genes to hepatocytes, correcting the genetic disorder. Vivet's ke...
    Vivet Therapeutics is a gene therapy biotech company with headquarters in Paris, France, dedicated to the research, development and future commercialization of gene therapy treatments for inherited liver disorders with high medical need. The company's development strategy is to target the liver using a liver tropic adeno associated virus to introduce therapeutic genes to hepatocytes, correcting the genetic disorder. Vivet's keys to success are its exclusive license rights and access to know how granted by its strategic partner, FIMA, enabling it to address various inherited disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vivet TherapeuticsFrance Flag
    Country
    Country
    France
    Address
    Address
    29 rue Tronchet 75008 Paris
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vivet-therapeutics.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vivettherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Vivet_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivet Presents Gene Therapy Data for Cerebrotendinous Xanthomatosis
    Vivet Presents Gene Therapy Data for Cerebrotendinous Xanthomatosis

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2980867/0/en/Vivet-Therapeutics-to-Present-Key-Findings-on-its-Gene-Therapy-Program-for-Cerebrotendinous-Xanthomatosis-at-the-American-Association-for-the-Study-of-Liver-Diseases-Annual-Meeting.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Vivet Presents Posters On Cerebrotendinous Xanthomatosis At ESGCT
    Vivet Presents Posters On Cerebrotendinous Xanthomatosis At ESGCT

    22 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/22/2966670/0/en/Vivet-Therapeutics-Presents-Three-Posters-on-Cerebrotendinous-Xanthomatosis-Program-and-Novel-AAV-Gene-Delivery-Platform-at-European-Society-of-Gene-and-Cell-Therapy-Annual-Congres.html

    GLOBENEWSWIRE
    22 Oct 2024
    Share Share
    Europe Grants Orphan Drug Designation for Vivet's Gene Therapy for CTX
    Europe Grants Orphan Drug Designation for Vivet's Gene Therapy for CTX

    05 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-grants-orphan-drug-designation-for-vivet-therapeutics-gene-therapy-product-for-the-treatment-of-cerebrotendinous-xanthomatosis-ctx-302238646.html

    PR NEWSWIRE
    05 Sep 2024
    Share Share
    Vivet Doses First Patient in Ph 1/2 GATEWAY Clinical Trial
    Vivet Doses First Patient in Ph 1/2 GATEWAY Clinical Trial

    08 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vivet-therapeutics-doses-first-patient-in-cohort-2-in-phase-12-gateway-clinical-trial-for-treatment-of-wilson-disease-302109330.html

    PR NEWSWIRE
    08 Apr 2024
    Share Share
    Vivet receives EUR 4.9 million to advance development of a gene therapy
    Vivet receives EUR 4.9 million to advance development of a gene therapy

    01 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vivet-therapeutics-receives-eur-4-9-million-to-advance-development-of-a-gene-therapy-for-the-treatment-of-cerebrotendinous-xanthomatosis-302049570.html

    PR NEWSWIRE
    01 Feb 2024
    Share Share
    Vivet Therapeutics Announces Presentations at Upcoming ESGCT
    Vivet Therapeutics Announces Presentations at Upcoming ESGCT

    23 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/23/2764603/0/en/Vivet-Therapeutics-Announces-Presentations-at-Upcoming-European-Society-of-Gene-and-Cell-Therapy-ESGCT-2023-Annual-Congress.html

    GLOBENEWSWIRE
    23 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search